nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—ALB—Irinotecan—colon cancer	0.0735	0.402	CbGbCtD
Acitretin—ALB—Fluorouracil—colon cancer	0.0705	0.386	CbGbCtD
Acitretin—ALB—Methotrexate—colon cancer	0.0389	0.213	CbGbCtD
Acitretin—CYP26A1—embryo—colon cancer	0.0161	0.11	CbGeAlD
Acitretin—RBP1—embryo—colon cancer	0.00961	0.0656	CbGeAlD
Acitretin—RBP1—epithelium—colon cancer	0.00785	0.0535	CbGeAlD
Acitretin—RBP1—smooth muscle tissue—colon cancer	0.00756	0.0516	CbGeAlD
Acitretin—RXRA—renal system—colon cancer	0.0075	0.0511	CbGeAlD
Acitretin—CYP26A1—liver—colon cancer	0.00745	0.0508	CbGeAlD
Acitretin—RBP1—renal system—colon cancer	0.00728	0.0496	CbGeAlD
Acitretin—ALB—gall bladder—colon cancer	0.00607	0.0414	CbGeAlD
Acitretin—RBP1—digestive system—colon cancer	0.00597	0.0407	CbGeAlD
Acitretin—RBP1—vagina—colon cancer	0.00527	0.0359	CbGeAlD
Acitretin—RARA—renal system—colon cancer	0.00516	0.0352	CbGeAlD
Acitretin—RARB—vagina—colon cancer	0.00488	0.0333	CbGeAlD
Acitretin—RXRA—liver—colon cancer	0.00458	0.0312	CbGeAlD
Acitretin—RARG—digestive system—colon cancer	0.00451	0.0307	CbGeAlD
Acitretin—RXRB—vagina—colon cancer	0.00448	0.0306	CbGeAlD
Acitretin—RBP1—liver—colon cancer	0.00445	0.0303	CbGeAlD
Acitretin—RARA—lymphoid tissue—colon cancer	0.00429	0.0292	CbGeAlD
Acitretin—RARB—liver—colon cancer	0.00411	0.0281	CbGeAlD
Acitretin—RARG—vagina—colon cancer	0.00398	0.0271	CbGeAlD
Acitretin—RARA—bone marrow—colon cancer	0.0039	0.0266	CbGeAlD
Acitretin—RXRB—liver—colon cancer	0.00378	0.0258	CbGeAlD
Acitretin—RBP1—lymph node—colon cancer	0.00341	0.0232	CbGeAlD
Acitretin—RARA—liver—colon cancer	0.00316	0.0215	CbGeAlD
Acitretin—RARB—lymph node—colon cancer	0.00315	0.0215	CbGeAlD
Acitretin—RARG—lymph node—colon cancer	0.00257	0.0175	CbGeAlD
Acitretin—RARA—lymph node—colon cancer	0.00242	0.0165	CbGeAlD
Acitretin—ALB—liver—colon cancer	0.00178	0.0121	CbGeAlD
Acitretin—ALB—lymph node—colon cancer	0.00136	0.0093	CbGeAlD
Acitretin—RXRA—PPAR Alpha Pathway—MYC—colon cancer	0.000826	0.00266	CbGpPWpGaD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.000824	0.00266	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—LGR5—colon cancer	0.000821	0.00265	CbGpPWpGaD
Acitretin—Osteoarthritis—Capecitabine—colon cancer	0.000819	0.00228	CcSEcCtD
Acitretin—Visual impairment—Irinotecan—colon cancer	0.000816	0.00227	CcSEcCtD
Acitretin—RXRG—Adipogenesis—PPARG—colon cancer	0.000816	0.00263	CbGpPWpGaD
Acitretin—Haemoglobin—Fluorouracil—colon cancer	0.000815	0.00226	CcSEcCtD
Acitretin—Rhinitis—Fluorouracil—colon cancer	0.000813	0.00226	CcSEcCtD
Acitretin—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000812	0.00226	CcSEcCtD
Acitretin—Haemorrhage—Fluorouracil—colon cancer	0.000811	0.00225	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00081	0.00261	CbGpPWpGaD
Acitretin—Hypoaesthesia—Fluorouracil—colon cancer	0.000807	0.00224	CcSEcCtD
Acitretin—Migraine—Capecitabine—colon cancer	0.000806	0.00224	CcSEcCtD
Acitretin—Pharyngitis—Fluorouracil—colon cancer	0.000805	0.00224	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000804	0.00259	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.000802	0.00259	CbGpPWpGaD
Acitretin—Skin exfoliation—Methotrexate—colon cancer	0.000802	0.00223	CcSEcCtD
Acitretin—CYP26A1—Metabolism—ODC1—colon cancer	0.0008	0.00258	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CHST5—colon cancer	0.0008	0.00258	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.0008	0.00258	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000796	0.00257	CbGpPWpGaD
Acitretin—Angiopathy—Vincristine—colon cancer	0.000789	0.00219	CcSEcCtD
Acitretin—Flushing—Irinotecan—colon cancer	0.000786	0.00218	CcSEcCtD
Acitretin—Alopecia—Vincristine—colon cancer	0.000768	0.00213	CcSEcCtD
Acitretin—Angiopathy—Irinotecan—colon cancer	0.000768	0.00213	CcSEcCtD
Acitretin—Blood creatinine increased—Capecitabine—colon cancer	0.000767	0.00213	CcSEcCtD
Acitretin—RARA—Adipogenesis—PPARG—colon cancer	0.000767	0.00247	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000767	0.00247	CbGpPWpGaD
Acitretin—Immune system disorder—Irinotecan—colon cancer	0.000765	0.00212	CcSEcCtD
Acitretin—Chills—Irinotecan—colon cancer	0.00076	0.00211	CcSEcCtD
Acitretin—Mouth ulceration—Methotrexate—colon cancer	0.000759	0.00211	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—CTNNB1—colon cancer	0.000758	0.00244	CbGpPWpGaD
Acitretin—Liver function test abnormal—Capecitabine—colon cancer	0.000756	0.0021	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.000754	0.00243	CbGpPWpGaD
Acitretin—Dry skin—Capecitabine—colon cancer	0.000751	0.00209	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—HNF4A—colon cancer	0.00075	0.00242	CbGpPWpGaD
Acitretin—Alopecia—Irinotecan—colon cancer	0.000748	0.00208	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—CDKN1A—colon cancer	0.00074	0.00239	CbGpPWpGaD
Acitretin—Back pain—Vincristine—colon cancer	0.000732	0.00203	CcSEcCtD
Acitretin—Gastritis—Capecitabine—colon cancer	0.000725	0.00201	CcSEcCtD
Acitretin—Muscular weakness—Capecitabine—colon cancer	0.000722	0.00201	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000722	0.00201	CcSEcCtD
Acitretin—Alopecia—Fluorouracil—colon cancer	0.000716	0.00199	CcSEcCtD
Acitretin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.000715	0.0023	CbGpPWpGaD
Acitretin—Back pain—Irinotecan—colon cancer	0.000713	0.00198	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.000708	0.00228	CbGpPWpGaD
Acitretin—Muscle spasms—Irinotecan—colon cancer	0.000708	0.00197	CcSEcCtD
Acitretin—Erythema—Fluorouracil—colon cancer	0.000706	0.00196	CcSEcCtD
Acitretin—Diabetes mellitus—Methotrexate—colon cancer	0.000701	0.00195	CcSEcCtD
Acitretin—Photosensitivity—Methotrexate—colon cancer	0.000694	0.00193	CcSEcCtD
Acitretin—Sweating increased—Capecitabine—colon cancer	0.000689	0.00192	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—HNF4A—colon cancer	0.000686	0.00221	CbGpPWpGaD
Acitretin—Ill-defined disorder—Irinotecan—colon cancer	0.000684	0.0019	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000677	0.00218	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—HNF4A—colon cancer	0.000673	0.00217	CbGpPWpGaD
Acitretin—Pancytopenia—Capecitabine—colon cancer	0.000672	0.00187	CcSEcCtD
Acitretin—Vision blurred—Fluorouracil—colon cancer	0.000665	0.00185	CcSEcCtD
Acitretin—Malaise—Irinotecan—colon cancer	0.000664	0.00185	CcSEcCtD
Acitretin—Dysuria—Capecitabine—colon cancer	0.000662	0.00184	CcSEcCtD
Acitretin—Dermatitis exfoliative—Methotrexate—colon cancer	0.000646	0.0018	CcSEcCtD
Acitretin—Photosensitivity reaction—Capecitabine—colon cancer	0.000646	0.0018	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—HNF4A—colon cancer	0.000645	0.00208	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—HNF4A—colon cancer	0.000645	0.00208	CbGpPWpGaD
Acitretin—Myalgia—Vincristine—colon cancer	0.000644	0.00179	CcSEcCtD
Acitretin—Weight increased—Capecitabine—colon cancer	0.000644	0.00179	CcSEcCtD
Acitretin—Visual disturbance—Methotrexate—colon cancer	0.000643	0.00179	CcSEcCtD
Acitretin—Cough—Irinotecan—colon cancer	0.000643	0.00179	CcSEcCtD
Acitretin—Weight decreased—Capecitabine—colon cancer	0.00064	0.00178	CcSEcCtD
Acitretin—Depression—Capecitabine—colon cancer	0.000629	0.00175	CcSEcCtD
Acitretin—Cerebrovascular accident—Methotrexate—colon cancer	0.000622	0.00173	CcSEcCtD
Acitretin—Discomfort—Irinotecan—colon cancer	0.00062	0.00172	CcSEcCtD
Acitretin—Neuropathy peripheral—Capecitabine—colon cancer	0.000619	0.00172	CcSEcCtD
Acitretin—Oedema—Vincristine—colon cancer	0.000618	0.00172	CcSEcCtD
Acitretin—Stomatitis—Capecitabine—colon cancer	0.000615	0.00171	CcSEcCtD
Acitretin—Jaundice—Capecitabine—colon cancer	0.000615	0.00171	CcSEcCtD
Acitretin—Infection—Vincristine—colon cancer	0.000613	0.00171	CcSEcCtD
Acitretin—Conjunctivitis—Capecitabine—colon cancer	0.000613	0.0017	CcSEcCtD
Acitretin—Urinary tract infection—Capecitabine—colon cancer	0.000613	0.0017	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—TGFB1—colon cancer	0.000612	0.00197	CbGpPWpGaD
Acitretin—Osteoarthritis—Methotrexate—colon cancer	0.00061	0.00169	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000609	0.00196	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—colon cancer	0.000608	0.00196	CbGpPWpGaD
Acitretin—Haematuria—Capecitabine—colon cancer	0.000602	0.00167	CcSEcCtD
Acitretin—Oedema—Irinotecan—colon cancer	0.000601	0.00167	CcSEcCtD
Acitretin—Myalgia—Fluorouracil—colon cancer	0.000601	0.00167	CcSEcCtD
Acitretin—Chest pain—Fluorouracil—colon cancer	0.000601	0.00167	CcSEcCtD
Acitretin—Infection—Irinotecan—colon cancer	0.000597	0.00166	CcSEcCtD
Acitretin—Hyperhidrosis—Vincristine—colon cancer	0.000597	0.00166	CcSEcCtD
Acitretin—Epistaxis—Capecitabine—colon cancer	0.000595	0.00165	CcSEcCtD
Acitretin—Discomfort—Fluorouracil—colon cancer	0.000594	0.00165	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—AXIN2—colon cancer	0.00059	0.0019	CbGpPWpGaD
Acitretin—Anorexia—Vincristine—colon cancer	0.000589	0.00164	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000584	0.00188	CbGpPWpGaD
Acitretin—Hyperhidrosis—Irinotecan—colon cancer	0.000581	0.00162	CcSEcCtD
Acitretin—Oedema—Fluorouracil—colon cancer	0.000576	0.0016	CcSEcCtD
Acitretin—RXRG—Adipogenesis—CTNNB1—colon cancer	0.000574	0.00185	CbGpPWpGaD
Acitretin—Anorexia—Irinotecan—colon cancer	0.000573	0.00159	CcSEcCtD
Acitretin—Infection—Fluorouracil—colon cancer	0.000572	0.00159	CcSEcCtD
Acitretin—Haemoglobin—Capecitabine—colon cancer	0.000569	0.00158	CcSEcCtD
Acitretin—Rhinitis—Capecitabine—colon cancer	0.000568	0.00158	CcSEcCtD
Acitretin—Haemorrhage—Capecitabine—colon cancer	0.000567	0.00157	CcSEcCtD
Acitretin—Hepatitis—Capecitabine—colon cancer	0.000567	0.00157	CcSEcCtD
Acitretin—Hypoaesthesia—Capecitabine—colon cancer	0.000564	0.00157	CcSEcCtD
Acitretin—Liver function test abnormal—Methotrexate—colon cancer	0.000563	0.00156	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000563	0.00156	CcSEcCtD
Acitretin—Pharyngitis—Capecitabine—colon cancer	0.000562	0.00156	CcSEcCtD
Acitretin—RXRG—Adipogenesis—CDKN1A—colon cancer	0.000561	0.00181	CbGpPWpGaD
Acitretin—Insomnia—Vincristine—colon cancer	0.000559	0.00155	CcSEcCtD
Acitretin—Oedema peripheral—Capecitabine—colon cancer	0.000558	0.00155	CcSEcCtD
Acitretin—Paraesthesia—Vincristine—colon cancer	0.000554	0.00154	CcSEcCtD
Acitretin—Anorexia—Fluorouracil—colon cancer	0.000549	0.00153	CcSEcCtD
Acitretin—Visual impairment—Capecitabine—colon cancer	0.000546	0.00152	CcSEcCtD
Acitretin—Insomnia—Irinotecan—colon cancer	0.000544	0.00151	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000541	0.00174	CbGpPWpGaD
Acitretin—Paraesthesia—Irinotecan—colon cancer	0.00054	0.0015	CcSEcCtD
Acitretin—RARA—Adipogenesis—CTNNB1—colon cancer	0.00054	0.00174	CbGpPWpGaD
Acitretin—Decreased appetite—Vincristine—colon cancer	0.000537	0.00149	CcSEcCtD
Acitretin—RXRA—Regulation of Androgen receptor activity—EP300—colon cancer	0.000536	0.00173	CbGpPWpGaD
Acitretin—Somnolence—Irinotecan—colon cancer	0.000535	0.00149	CcSEcCtD
Acitretin—Gastrointestinal disorder—Vincristine—colon cancer	0.000533	0.00148	CcSEcCtD
Acitretin—Fatigue—Vincristine—colon cancer	0.000532	0.00148	CcSEcCtD
Acitretin—Eye disorder—Capecitabine—colon cancer	0.000529	0.00147	CcSEcCtD
Acitretin—Dyspepsia—Irinotecan—colon cancer	0.000529	0.00147	CcSEcCtD
Acitretin—Tinnitus—Capecitabine—colon cancer	0.000528	0.00147	CcSEcCtD
Acitretin—Constipation—Vincristine—colon cancer	0.000528	0.00147	CcSEcCtD
Acitretin—Pain—Vincristine—colon cancer	0.000528	0.00147	CcSEcCtD
Acitretin—RARA—Adipogenesis—CDKN1A—colon cancer	0.000527	0.0017	CbGpPWpGaD
Acitretin—Flushing—Capecitabine—colon cancer	0.000526	0.00146	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000525	0.00146	CcSEcCtD
Acitretin—Decreased appetite—Irinotecan—colon cancer	0.000523	0.00145	CcSEcCtD
Acitretin—RXRA—Regulation of Androgen receptor activity—SRC—colon cancer	0.000521	0.00168	CbGpPWpGaD
Acitretin—Insomnia—Fluorouracil—colon cancer	0.000521	0.00145	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.000521	0.00168	CbGpPWpGaD
Acitretin—RXRA—Circadian Clock—EP300—colon cancer	0.00052	0.00168	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000519	0.00144	CcSEcCtD
Acitretin—Fatigue—Irinotecan—colon cancer	0.000518	0.00144	CcSEcCtD
Acitretin—Paraesthesia—Fluorouracil—colon cancer	0.000517	0.00144	CcSEcCtD
Acitretin—Pancreatitis—Methotrexate—colon cancer	0.000517	0.00144	CcSEcCtD
Acitretin—Alitretinoin—ABCB1—colon cancer	0.000515	1	CrCbGaD
Acitretin—Constipation—Irinotecan—colon cancer	0.000514	0.00143	CcSEcCtD
Acitretin—Pain—Irinotecan—colon cancer	0.000514	0.00143	CcSEcCtD
Acitretin—Angiopathy—Capecitabine—colon cancer	0.000514	0.00143	CcSEcCtD
Acitretin—Somnolence—Fluorouracil—colon cancer	0.000512	0.00142	CcSEcCtD
Acitretin—Immune system disorder—Capecitabine—colon cancer	0.000512	0.00142	CcSEcCtD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.000511	0.00165	CbGpPWpGaD
Acitretin—Chills—Capecitabine—colon cancer	0.000508	0.00141	CcSEcCtD
Acitretin—Dyspepsia—Fluorouracil—colon cancer	0.000507	0.00141	CcSEcCtD
Acitretin—Gastrointestinal pain—Vincristine—colon cancer	0.000505	0.0014	CcSEcCtD
Acitretin—Decreased appetite—Fluorouracil—colon cancer	0.000501	0.00139	CcSEcCtD
Acitretin—Alopecia—Capecitabine—colon cancer	0.000501	0.00139	CcSEcCtD
Acitretin—Pancytopenia—Methotrexate—colon cancer	0.0005	0.00139	CcSEcCtD
Acitretin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000497	0.00138	CcSEcCtD
Acitretin—Feeling abnormal—Irinotecan—colon cancer	0.000496	0.00138	CcSEcCtD
Acitretin—Erythema—Capecitabine—colon cancer	0.000493	0.00137	CcSEcCtD
Acitretin—Dysuria—Methotrexate—colon cancer	0.000493	0.00137	CcSEcCtD
Acitretin—Pain—Fluorouracil—colon cancer	0.000493	0.00137	CcSEcCtD
Acitretin—Gastrointestinal pain—Irinotecan—colon cancer	0.000492	0.00137	CcSEcCtD
Acitretin—RXRA—Metabolism—CA7—colon cancer	0.00049	0.00158	CbGpPWpGaD
Acitretin—Abdominal pain—Vincristine—colon cancer	0.000488	0.00136	CcSEcCtD
Acitretin—Body temperature increased—Vincristine—colon cancer	0.000488	0.00136	CcSEcCtD
Acitretin—Erectile dysfunction—Methotrexate—colon cancer	0.000485	0.00135	CcSEcCtD
Acitretin—Dysgeusia—Capecitabine—colon cancer	0.000483	0.00134	CcSEcCtD
Acitretin—Photosensitivity reaction—Methotrexate—colon cancer	0.000481	0.00134	CcSEcCtD
Acitretin—Back pain—Capecitabine—colon cancer	0.000477	0.00133	CcSEcCtD
Acitretin—Abdominal pain—Irinotecan—colon cancer	0.000475	0.00132	CcSEcCtD
Acitretin—Body temperature increased—Irinotecan—colon cancer	0.000475	0.00132	CcSEcCtD
Acitretin—Feeling abnormal—Fluorouracil—colon cancer	0.000475	0.00132	CcSEcCtD
Acitretin—Muscle spasms—Capecitabine—colon cancer	0.000474	0.00132	CcSEcCtD
Acitretin—Depression—Methotrexate—colon cancer	0.000468	0.0013	CcSEcCtD
Acitretin—Vision blurred—Capecitabine—colon cancer	0.000465	0.00129	CcSEcCtD
Acitretin—RXRG—Adipogenesis—TGFB1—colon cancer	0.000464	0.0015	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000463	0.00149	CbGpPWpGaD
Acitretin—Stomatitis—Methotrexate—colon cancer	0.000458	0.00127	CcSEcCtD
Acitretin—Ill-defined disorder—Capecitabine—colon cancer	0.000458	0.00127	CcSEcCtD
Acitretin—Urticaria—Fluorouracil—colon cancer	0.000458	0.00127	CcSEcCtD
Acitretin—RXRA—PPARA activates gene expression—PPARG—colon cancer	0.000457	0.00147	CbGpPWpGaD
Acitretin—Conjunctivitis—Methotrexate—colon cancer	0.000457	0.00127	CcSEcCtD
Acitretin—Body temperature increased—Fluorouracil—colon cancer	0.000455	0.00127	CcSEcCtD
Acitretin—Hypersensitivity—Vincristine—colon cancer	0.000455	0.00126	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.000452	0.00146	CbGpPWpGaD
Acitretin—Haematuria—Methotrexate—colon cancer	0.000448	0.00124	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.000447	0.00144	CbGpPWpGaD
Acitretin—Malaise—Capecitabine—colon cancer	0.000445	0.00124	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000443	0.00143	CbGpPWpGaD
Acitretin—Epistaxis—Methotrexate—colon cancer	0.000443	0.00123	CcSEcCtD
Acitretin—Hypersensitivity—Irinotecan—colon cancer	0.000443	0.00123	CcSEcCtD
Acitretin—Asthenia—Vincristine—colon cancer	0.000443	0.00123	CcSEcCtD
Acitretin—RARA—Adipogenesis—TGFB1—colon cancer	0.000436	0.00141	CbGpPWpGaD
Acitretin—Asthenia—Irinotecan—colon cancer	0.000431	0.0012	CcSEcCtD
Acitretin—Cough—Capecitabine—colon cancer	0.00043	0.0012	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000429	0.00138	CbGpPWpGaD
Acitretin—Hypersensitivity—Fluorouracil—colon cancer	0.000424	0.00118	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—colon cancer	0.000424	0.00118	CcSEcCtD
Acitretin—Diarrhoea—Vincristine—colon cancer	0.000423	0.00117	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000422	0.00136	CbGpPWpGaD
Acitretin—Hepatitis—Methotrexate—colon cancer	0.000422	0.00117	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—colon cancer	0.000422	0.00117	CcSEcCtD
Acitretin—Arthralgia—Capecitabine—colon cancer	0.00042	0.00117	CcSEcCtD
Acitretin—Chest pain—Capecitabine—colon cancer	0.00042	0.00117	CcSEcCtD
Acitretin—Myalgia—Capecitabine—colon cancer	0.00042	0.00117	CcSEcCtD
Acitretin—Pharyngitis—Methotrexate—colon cancer	0.000419	0.00116	CcSEcCtD
Acitretin—Anxiety—Capecitabine—colon cancer	0.000418	0.00116	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.000418	0.00135	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000418	0.00135	CbGpPWpGaD
Acitretin—Discomfort—Capecitabine—colon cancer	0.000415	0.00115	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000415	0.00134	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000414	0.00133	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000412	0.00133	CbGpPWpGaD
Acitretin—Diarrhoea—Irinotecan—colon cancer	0.000411	0.00114	CcSEcCtD
Acitretin—Dry mouth—Capecitabine—colon cancer	0.000411	0.00114	CcSEcCtD
Acitretin—Dizziness—Vincristine—colon cancer	0.000408	0.00113	CcSEcCtD
Acitretin—Pruritus—Fluorouracil—colon cancer	0.000407	0.00113	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—colon cancer	0.000406	0.00113	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000404	0.0013	CbGpPWpGaD
Acitretin—Oedema—Capecitabine—colon cancer	0.000402	0.00112	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000401	0.00129	CbGpPWpGaD
Acitretin—Infection—Capecitabine—colon cancer	0.0004	0.00111	CcSEcCtD
Acitretin—RXRA—Adipogenesis—PPARG—colon cancer	0.0004	0.00129	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000399	0.00129	CbGpPWpGaD
Acitretin—Dizziness—Irinotecan—colon cancer	0.000398	0.00111	CcSEcCtD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	0.000398	0.00128	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000397	0.00128	CbGpPWpGaD
Acitretin—Eye disorder—Methotrexate—colon cancer	0.000394	0.0011	CcSEcCtD
Acitretin—Diarrhoea—Fluorouracil—colon cancer	0.000394	0.0011	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—colon cancer	0.000393	0.00109	CcSEcCtD
Acitretin—Vomiting—Vincristine—colon cancer	0.000393	0.00109	CcSEcCtD
Acitretin—Skin disorder—Capecitabine—colon cancer	0.000391	0.00109	CcSEcCtD
Acitretin—Rash—Vincristine—colon cancer	0.000389	0.00108	CcSEcCtD
Acitretin—Hyperhidrosis—Capecitabine—colon cancer	0.000389	0.00108	CcSEcCtD
Acitretin—Dermatitis—Vincristine—colon cancer	0.000389	0.00108	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000388	0.00125	CbGpPWpGaD
Acitretin—Headache—Vincristine—colon cancer	0.000387	0.00108	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000385	0.00124	CbGpPWpGaD
Acitretin—Anorexia—Capecitabine—colon cancer	0.000384	0.00107	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—colon cancer	0.000383	0.00106	CcSEcCtD
Acitretin—Vomiting—Irinotecan—colon cancer	0.000382	0.00106	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—colon cancer	0.000381	0.00106	CcSEcCtD
Acitretin—Dizziness—Fluorouracil—colon cancer	0.000381	0.00106	CcSEcCtD
Acitretin—Rash—Irinotecan—colon cancer	0.000379	0.00105	CcSEcCtD
Acitretin—Dermatitis—Irinotecan—colon cancer	0.000379	0.00105	CcSEcCtD
Acitretin—Chills—Methotrexate—colon cancer	0.000378	0.00105	CcSEcCtD
Acitretin—Headache—Irinotecan—colon cancer	0.000377	0.00105	CcSEcCtD
Acitretin—RXRA—Developmental Biology—DCC—colon cancer	0.000376	0.00121	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000374	0.00121	CbGpPWpGaD
Acitretin—Alopecia—Methotrexate—colon cancer	0.000373	0.00104	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.000369	0.00119	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000369	0.00119	CbGpPWpGaD
Acitretin—Erythema—Methotrexate—colon cancer	0.000367	0.00102	CcSEcCtD
Acitretin—Nausea—Vincristine—colon cancer	0.000367	0.00102	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000367	0.00102	CcSEcCtD
Acitretin—Vomiting—Fluorouracil—colon cancer	0.000366	0.00102	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000364	0.00117	CbGpPWpGaD
Acitretin—Insomnia—Capecitabine—colon cancer	0.000364	0.00101	CcSEcCtD
Acitretin—Rash—Fluorouracil—colon cancer	0.000363	0.00101	CcSEcCtD
Acitretin—Dermatitis—Fluorouracil—colon cancer	0.000363	0.00101	CcSEcCtD
Acitretin—Paraesthesia—Capecitabine—colon cancer	0.000361	0.001	CcSEcCtD
Acitretin—RARG—Gene Expression—HNF4A—colon cancer	0.000361	0.00116	CbGpPWpGaD
Acitretin—Headache—Fluorouracil—colon cancer	0.000361	0.001	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—colon cancer	0.00036	0.000999	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000359	0.00116	CbGpPWpGaD
Acitretin—Nausea—Irinotecan—colon cancer	0.000357	0.000993	CcSEcCtD
Acitretin—Back pain—Methotrexate—colon cancer	0.000355	0.000987	CcSEcCtD
Acitretin—Dyspepsia—Capecitabine—colon cancer	0.000354	0.000985	CcSEcCtD
Acitretin—Decreased appetite—Capecitabine—colon cancer	0.00035	0.000972	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000349	0.00113	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000347	0.000966	CcSEcCtD
Acitretin—Fatigue—Capecitabine—colon cancer	0.000347	0.000964	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—colon cancer	0.000346	0.000962	CcSEcCtD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	0.000346	0.00111	CbGpPWpGaD
Acitretin—Constipation—Capecitabine—colon cancer	0.000344	0.000957	CcSEcCtD
Acitretin—Pain—Capecitabine—colon cancer	0.000344	0.000957	CcSEcCtD
Acitretin—Nausea—Fluorouracil—colon cancer	0.000342	0.000951	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—colon cancer	0.000341	0.000947	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—HNF4A—colon cancer	0.000336	0.00108	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000335	0.00108	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000334	0.00108	CbGpPWpGaD
Acitretin—Feeling abnormal—Capecitabine—colon cancer	0.000332	0.000922	CcSEcCtD
Acitretin—Malaise—Methotrexate—colon cancer	0.000331	0.00092	CcSEcCtD
Acitretin—RXRG—Gene Expression—HNF4A—colon cancer	0.00033	0.00106	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Capecitabine—colon cancer	0.000329	0.000915	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000328	0.00106	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—PPARG—colon cancer	0.000326	0.00105	CbGpPWpGaD
Acitretin—RARB—Gene Expression—HNF4A—colon cancer	0.000324	0.00104	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000321	0.00104	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000321	0.00103	CbGpPWpGaD
Acitretin—Cough—Methotrexate—colon cancer	0.00032	0.00089	CcSEcCtD
Acitretin—Urticaria—Capecitabine—colon cancer	0.00032	0.000889	CcSEcCtD
Acitretin—Abdominal pain—Capecitabine—colon cancer	0.000318	0.000884	CcSEcCtD
Acitretin—Body temperature increased—Capecitabine—colon cancer	0.000318	0.000884	CcSEcCtD
Acitretin—RXRA—Developmental Biology—HNF4A—colon cancer	0.000316	0.00102	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000314	0.00101	CbGpPWpGaD
Acitretin—Myalgia—Methotrexate—colon cancer	0.000313	0.000869	CcSEcCtD
Acitretin—Chest pain—Methotrexate—colon cancer	0.000313	0.000869	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—colon cancer	0.000313	0.000869	CcSEcCtD
Acitretin—RXRB—Gene Expression—HNF4A—colon cancer	0.000311	0.001	CbGpPWpGaD
Acitretin—RARA—Gene Expression—HNF4A—colon cancer	0.000311	0.001	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.00031	0.000999	CbGpPWpGaD
Acitretin—Discomfort—Methotrexate—colon cancer	0.000309	0.000858	CcSEcCtD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000308	0.000993	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000304	0.000982	CbGpPWpGaD
Acitretin—RXRA—PPARA activates gene expression—EP300—colon cancer	0.000299	0.000964	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—PPARG—colon cancer	0.000298	0.00096	CbGpPWpGaD
Acitretin—Infection—Methotrexate—colon cancer	0.000298	0.000827	CcSEcCtD
Acitretin—RXRA—Metabolism—ODC1—colon cancer	0.000297	0.000958	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CHST5—colon cancer	0.000297	0.000958	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000297	0.000958	CbGpPWpGaD
Acitretin—Hypersensitivity—Capecitabine—colon cancer	0.000297	0.000824	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000293	0.000943	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—PPARG—colon cancer	0.000292	0.000942	CbGpPWpGaD
Acitretin—Skin disorder—Methotrexate—colon cancer	0.000291	0.000809	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—colon cancer	0.00029	0.000805	CcSEcCtD
Acitretin—Asthenia—Capecitabine—colon cancer	0.000289	0.000803	CcSEcCtD
Acitretin—Anorexia—Methotrexate—colon cancer	0.000286	0.000794	CcSEcCtD
Acitretin—Pruritus—Capecitabine—colon cancer	0.000285	0.000791	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000285	0.000918	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CTNNB1—colon cancer	0.000281	0.000907	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—PPARG—colon cancer	0.00028	0.000903	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—PPARG—colon cancer	0.00028	0.000903	CbGpPWpGaD
Acitretin—Diarrhoea—Capecitabine—colon cancer	0.000275	0.000765	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000275	0.000888	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CDKN1A—colon cancer	0.000275	0.000886	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000273	0.000759	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000273	0.00088	CbGpPWpGaD
Acitretin—Insomnia—Methotrexate—colon cancer	0.000271	0.000753	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—colon cancer	0.000269	0.000748	CcSEcCtD
Acitretin—Somnolence—Methotrexate—colon cancer	0.000266	0.00074	CcSEcCtD
Acitretin—Dizziness—Capecitabine—colon cancer	0.000266	0.00074	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000264	0.000851	CbGpPWpGaD
Acitretin—Dyspepsia—Methotrexate—colon cancer	0.000264	0.000733	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—colon cancer	0.00026	0.000724	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000259	0.000719	CcSEcCtD
Acitretin—Fatigue—Methotrexate—colon cancer	0.000258	0.000718	CcSEcCtD
Acitretin—Pain—Methotrexate—colon cancer	0.000256	0.000712	CcSEcCtD
Acitretin—Vomiting—Capecitabine—colon cancer	0.000256	0.000711	CcSEcCtD
Acitretin—Rash—Capecitabine—colon cancer	0.000254	0.000705	CcSEcCtD
Acitretin—Dermatitis—Capecitabine—colon cancer	0.000254	0.000705	CcSEcCtD
Acitretin—Headache—Capecitabine—colon cancer	0.000252	0.000701	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—colon cancer	0.000247	0.000686	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—colon cancer	0.000245	0.000681	CcSEcCtD
Acitretin—RBP1—Disease—FGFR3—colon cancer	0.000243	0.000784	CbGpPWpGaD
Acitretin—Nausea—Capecitabine—colon cancer	0.000239	0.000664	CcSEcCtD
Acitretin—Urticaria—Methotrexate—colon cancer	0.000238	0.000662	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—colon cancer	0.000237	0.000658	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—colon cancer	0.000237	0.000658	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000232	0.00075	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000231	0.000745	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—TGFB1—colon cancer	0.000227	0.000733	CbGpPWpGaD
Acitretin—ALB—Metabolism—CA7—colon cancer	0.000224	0.000721	CbGpPWpGaD
Acitretin—RBP1—Disease—APC—colon cancer	0.000223	0.00072	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000223	0.000719	CbGpPWpGaD
Acitretin—Hypersensitivity—Methotrexate—colon cancer	0.000221	0.000614	CcSEcCtD
Acitretin—Asthenia—Methotrexate—colon cancer	0.000215	0.000597	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000215	0.000692	CbGpPWpGaD
Acitretin—Pruritus—Methotrexate—colon cancer	0.000212	0.000589	CcSEcCtD
Acitretin—CYP26A1—Metabolism—ABCB1—colon cancer	0.000211	0.000682	CbGpPWpGaD
Acitretin—RBP1—Disease—BRAF—colon cancer	0.00021	0.000677	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000209	0.000673	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—TYMS—colon cancer	0.000208	0.00067	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—TGFB1—colon cancer	0.000207	0.000668	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000207	0.000667	CbGpPWpGaD
Acitretin—Diarrhoea—Methotrexate—colon cancer	0.000205	0.00057	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000202	0.000651	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000202	0.00065	CbGpPWpGaD
Acitretin—Dizziness—Methotrexate—colon cancer	0.000198	0.000551	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	0.000196	0.000632	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000192	0.00062	CbGpPWpGaD
Acitretin—Vomiting—Methotrexate—colon cancer	0.000191	0.000529	CcSEcCtD
Acitretin—Rash—Methotrexate—colon cancer	0.000189	0.000525	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—colon cancer	0.000189	0.000525	CcSEcCtD
Acitretin—Headache—Methotrexate—colon cancer	0.000188	0.000522	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000187	0.000603	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—MYC—colon cancer	0.000186	0.000599	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000182	0.000587	CbGpPWpGaD
Acitretin—Nausea—Methotrexate—colon cancer	0.000178	0.000495	CcSEcCtD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000171	0.000553	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGFR3—colon cancer	0.00017	0.000549	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—colon cancer	0.00017	0.000548	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—colon cancer	0.00017	0.000547	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000168	0.000541	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000167	0.00054	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000167	0.000539	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—colon cancer	0.000167	0.000537	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—colon cancer	0.000167	0.000537	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000164	0.000528	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HNF4A—colon cancer	0.000162	0.000522	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—colon cancer	0.00016	0.000515	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—colon cancer	0.00016	0.000515	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	0.000159	0.000512	CbGpPWpGaD
Acitretin—RARG—Gene Expression—PPARG—colon cancer	0.000157	0.000506	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APC—colon cancer	0.000156	0.000504	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000155	0.000499	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—TGFB1—colon cancer	0.000153	0.000493	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—colon cancer	0.000152	0.000489	CbGpPWpGaD
Acitretin—RBP1—Disease—CDKN1A—colon cancer	0.000148	0.000478	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PPARG—colon cancer	0.000147	0.000474	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BRAF—colon cancer	0.000147	0.000474	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—colon cancer	0.000147	0.000473	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—colon cancer	0.000146	0.000471	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	0.000146	0.00047	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PPARG—colon cancer	0.000143	0.000462	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000142	0.000458	CbGpPWpGaD
Acitretin—RBP1—Disease—EP300—colon cancer	0.000141	0.000455	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PPARG—colon cancer	0.000141	0.000453	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000138	0.000444	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—colon cancer	0.000137	0.000443	CbGpPWpGaD
Acitretin—RBP1—Disease—SRC—colon cancer	0.000137	0.000442	CbGpPWpGaD
Acitretin—ALB—Metabolism—ODC1—colon cancer	0.000136	0.000437	CbGpPWpGaD
Acitretin—ALB—Metabolism—CHST5—colon cancer	0.000136	0.000437	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—colon cancer	0.000135	0.000435	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPARG—colon cancer	0.000135	0.000435	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—colon cancer	0.000132	0.000425	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—colon cancer	0.000123	0.000396	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000123	0.000396	CbGpPWpGaD
Acitretin—RBP1—Disease—TGFB1—colon cancer	0.000123	0.000395	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—colon cancer	0.00012	0.000388	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000116	0.000375	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—colon cancer	0.000116	0.000373	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—colon cancer	0.000114	0.000366	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—colon cancer	0.00011	0.000355	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—colon cancer	0.000107	0.000346	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—colon cancer	0.000106	0.000343	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—colon cancer	0.000104	0.000336	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—colon cancer	0.000104	0.000335	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EP300—colon cancer	9.87e-05	0.000318	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—colon cancer	9.67e-05	0.000312	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.65e-05	0.000311	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—colon cancer	9.65e-05	0.000311	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—EP300—colon cancer	9.63e-05	0.00031	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—colon cancer	9.6e-05	0.00031	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—colon cancer	9.35e-05	0.000302	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—colon cancer	9.24e-05	0.000298	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EP300—colon cancer	8.99e-05	0.00029	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—colon cancer	8.94e-05	0.000288	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SRC—colon cancer	8.74e-05	0.000282	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—colon cancer	8.6e-05	0.000277	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TGFB1—colon cancer	8.58e-05	0.000277	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—colon cancer	8.52e-05	0.000275	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—colon cancer	8.51e-05	0.000274	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—colon cancer	8.42e-05	0.000271	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—colon cancer	8.41e-05	0.000271	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—colon cancer	8.32e-05	0.000268	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—colon cancer	8.18e-05	0.000264	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.03e-05	0.000259	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—colon cancer	8.02e-05	0.000259	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—colon cancer	7.95e-05	0.000256	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—colon cancer	7.85e-05	0.000253	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TGFB1—colon cancer	7.81e-05	0.000252	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMS—colon cancer	7.71e-05	0.000249	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—colon cancer	7.69e-05	0.000248	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—colon cancer	7.69e-05	0.000248	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—colon cancer	7.66e-05	0.000247	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	7.65e-05	0.000247	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	7.59e-05	0.000245	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	7.39e-05	0.000238	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—colon cancer	7.3e-05	0.000236	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—colon cancer	7.24e-05	0.000233	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—colon cancer	7.12e-05	0.00023	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—colon cancer	7.07e-05	0.000228	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—colon cancer	7.03e-05	0.000227	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	6.78e-05	0.000219	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—colon cancer	6.76e-05	0.000218	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—colon cancer	6.2e-05	0.0002	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—colon cancer	6.15e-05	0.000198	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—colon cancer	5.97e-05	0.000192	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.94e-05	0.000191	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—colon cancer	5.82e-05	0.000188	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	5.77e-05	0.000186	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—colon cancer	5.67e-05	0.000183	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.6e-05	0.00018	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—colon cancer	5.56e-05	0.000179	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—colon cancer	5.46e-05	0.000176	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—colon cancer	5.43e-05	0.000175	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—colon cancer	5.33e-05	0.000172	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—colon cancer	5.33e-05	0.000172	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	4.71e-05	0.000152	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.4e-05	0.000142	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—colon cancer	4.3e-05	0.000139	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EP300—colon cancer	4.02e-05	0.00013	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—colon cancer	4.01e-05	0.000129	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—colon cancer	3.91e-05	0.000126	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—colon cancer	3.81e-05	0.000123	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—colon cancer	3.76e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.66e-05	0.000118	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—colon cancer	3.58e-05	0.000115	CbGpPWpGaD
Acitretin—RXRA—Metabolism—EP300—colon cancer	3.57e-05	0.000115	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMS—colon cancer	3.52e-05	0.000113	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TGFB1—colon cancer	3.5e-05	0.000113	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—colon cancer	3.24e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—colon cancer	2.97e-05	9.59e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—colon cancer	2.88e-05	9.28e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—colon cancer	2.78e-05	8.96e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—colon cancer	2.75e-05	8.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.71e-05	8.73e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—colon cancer	2.64e-05	8.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—colon cancer	2.49e-05	8.04e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—colon cancer	2.43e-05	7.84e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—colon cancer	2.16e-05	6.97e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—colon cancer	1.96e-05	6.32e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—EP300—colon cancer	1.63e-05	5.26e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—colon cancer	1.21e-05	3.89e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—colon cancer	9.85e-06	3.18e-05	CbGpPWpGaD
